Latest Period
Q2 2026
Security Snapshot
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) Institutional Ownership
CUSIP: 09062W204
13F Institutional Holders and Ownership History from Q2 2014 to Q2 2026
Institutions Reporting
211
Shares (Excl. Options)
49,403,508
Price
$28.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- BLFS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 49,403,508
- Total 13F value
- $1,394,705,222
- Portfolio coverage rank
- 0%
- Share change
- -471,921
- Value change
- -$5,250,461
- Number of holders
- 211
- Shares outstanding
- 49,042,938
- SEC-reported price per share
- $29.79
- Insider filing price
- $29.79
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 09062W204.
- 211 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 186 to 211 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $951,654,024 to $1,394,705,222.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 211 institutions filings for Q2 2026.
Security key
09062W204
Latest holder period
Q2 2026
13F holders
211
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
BLFS full holder history
BIOLIFE SOLUTIONS INC SEC filings
BIOLIFE SOLUTIONS INC company facts
BIOLIFE SOLUTIONS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09062W204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
BLFS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14% | +25% | $130,842,618 | +$26,656,247 | 6,506,346 | +26% | T. Rowe Price Investment Management, Inc. | 31 Mar 2026 |
| Casdin Capital, LLC | 9.7% | 0% | $100,709,183 | 4,757,165 | 0% | Casdin Capital, LLC | 04 Jun 2026 | |
| Invesco Ltd. | 4.9% | -41% | $47,228,979 | -$31,847,382 | 2,348,532 | -40% | Invesco Ltd. | 31 Mar 2026 |
As of 30 Jun 2026, 211 institutional investors reported holding 49,403,508 shares of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS). This represents 101% of the company’s total 49,042,938 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
78%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14% | 6,751,135 | +3.8% | 0.12% | $190,653,000 |
| BlackRock, Inc. | 13% | 6,375,545 | +4.5% | 0% | $180,045,391 |
| Casdin Capital, LLC | 9.5% | 4,655,000 | -22% | 6.6% | $131,457,200 |
| Invesco Ltd. | 4.6% | 2,240,423 | -4.6% | 0.01% | $63,269,546 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 1,964,084 | +2.4% | 0% | $55,465,732 |
| STATE STREET CORP | 3.4% | 1,655,927 | +5% | 0% | $46,767,343 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,086,865 | +12% | 0% | $30,698,163 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.2% | 1,079,270 | -9.9% | 0.01% | $30,478,584 |
| FRED ALGER MANAGEMENT, LLC | 2.2% | 1,077,577 | -0.22% | 0.1% | $30,430,774 |
| DIMENSIONAL FUND ADVISORS LP | 2.1% | 1,046,252 | +1% | 0.01% | $29,546,419 |
| FMR LLC | 2% | 993,106 | -32% | 0% | $28,045,309 |
| BANK OF AMERICA CORP /DE/ | 1.9% | 950,159 | +5.1% | 0% | $26,832,489 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 913,226 | +5.6% | 0% | $25,789,502 |
| ROYAL BANK OF CANADA | 1.8% | 890,908 | +0.64% | 0% | $25,159,000 |
| UBS Group AG | 1.7% | 832,143 | +213% | 0% | $23,499,718 |
| Stephens Investment Management Group LLC | 1.4% | 708,666 | +5.3% | 0.21% | $20,012,728 |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 625,658 | 0.01% | $17,668,582 | |
| ROYCE & ASSOCIATES LP | 1.3% | 623,875 | +6.8% | 0.14% | $17,618,230 |
| GENEVA CAPITAL MANAGEMENT LLC | 1.2% | 582,141 | -21% | 0.38% | $16,439,651 |
| CRAMER ROSENTHAL MCGLYNN LLC | 1.2% | 575,792 | -9% | 0.83% | $16,260,366 |
| NEXT CENTURY GROWTH INVESTORS LLC | 1.1% | 558,829 | +54% | 0.84% | $15,781,330 |
| GAGNON SECURITIES LLC | 1.1% | 535,906 | -0.11% | 2.9% | $15,133,985 |
| GOLDMAN SACHS GROUP INC | 1.1% | 531,582 | +100% | 0% | $15,011,875 |
| Granahan Investment Management, LLC | 1.1% | 521,430 | -28% | 0.52% | $14,725,183 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 1% | 496,511 | -13% | 0.14% | $14,021,471 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q2 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 49,403,508 | $1,394,705,222 | -$5,250,461 | $28.24 | 211 |
| 2026 Q1 | 49,884,763 | $951,654,024 | +$9,671,366 | $19.08 | 186 |
| 2025 Q4 | 48,929,492 | $1,183,329,416 | +$11,930,532 | $24.18 | 186 |
| 2025 Q3 | 48,107,711 | $1,227,205,552 | -$39,555,573 | $25.51 | 188 |
| 2025 Q2 | 49,891,551 | $1,074,666,783 | +$46,085,035 | $21.54 | 193 |
| 2025 Q1 | 47,668,681 | $1,088,709,499 | +$20,128,588 | $22.84 | 188 |
| 2024 Q4 | 46,805,050 | $1,214,970,700 | +$32,660,204 | $25.96 | 179 |
| 2024 Q3 | 45,256,383 | $1,133,546,998 | -$37,704,401 | $25.04 | 193 |
| 2024 Q2 | 46,759,086 | $1,001,701,609 | +$52,199,509 | $21.43 | 164 |
| 2024 Q1 | 44,406,426 | $823,506,297 | -$18,755,552 | $18.55 | 148 |
| 2023 Q4 | 45,388,256 | $737,705,671 | +$37,803,026 | $16.25 | 138 |
| 2023 Q3 | 43,572,418 | $601,804,361 | +$31,718,369 | $13.81 | 152 |
| 2023 Q2 | 40,574,468 | $896,734,819 | +$40,556,636 | $22.10 | 155 |
| 2023 Q1 | 38,757,969 | $842,823,822 | +$17,191,226 | $21.75 | 165 |
| 2022 Q4 | 38,161,776 | $694,539,798 | -$10,679,652 | $18.20 | 160 |
| 2022 Q3 | 38,421,067 | $874,137,954 | +$38,798,900 | $22.75 | 169 |
| 2022 Q2 | 36,797,091 | $508,323,451 | +$12,324,863 | $13.81 | 146 |
| 2022 Q1 | 35,131,386 | $798,491,817 | -$7,596,956 | $22.73 | 155 |
| 2021 Q4 | 34,958,126 | $1,302,914,183 | +$115,722,970 | $37.27 | 165 |
| 2021 Q3 | 31,670,115 | $1,340,574,104 | +$157,430,709 | $42.32 | 159 |
| 2021 Q2 | 27,974,612 | $1,245,139,856 | +$121,193,958 | $44.51 | 130 |
| 2021 Q1 | 25,413,123 | $914,855,472 | +$45,084,655 | $36.00 | 130 |
| 2020 Q4 | 24,231,900 | $966,664,009 | +$97,438,296 | $39.89 | 125 |
| 2020 Q3 | 22,145,073 | $640,866,936 | +$216,554,424 | $28.94 | 104 |
| 2020 Q2 | 14,927,170 | $244,144,153 | +$49,280,131 | $16.35 | 82 |